Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2009
03/18/2009EP2035375A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
03/18/2009EP2035374A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
03/18/2009EP2035373A1 Phenyl pyrrole aminoguanidine derivatives
03/18/2009EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
03/18/2009EP2035371A2 Substituted phenyl methanone derivatives
03/18/2009EP2035370A2 Tetralin and indane derivatives and uses thereof
03/18/2009EP2000125A9 Hair dyeing composition
03/18/2009EP1546103B1 Piperazine and piperidine derivatives for treatment of neurological diseases
03/18/2009EP1386912B1 Cyclic amidine derivative
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/18/2009CN101389617A Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
03/18/2009CN101389599A Modified amino acids
03/18/2009CN101386590A Pyrrolidone containing hydroxymethyl and carboxyl, preparation method and medicament composition and use thereof
03/18/2009CN100469766C Process for preparing N-cyclohexyl maleimide
03/17/2009USRE40667 [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
03/17/2009US7504532 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
03/17/2009US7504521 Methods for the preparation of pyrrolotriazine compounds
03/17/2009US7504520 8-({5-[4-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl}amino)-3,4-dihydronaphthalen-2(1H) one; treating pain, bladder overactivity, and urinary incontinence
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504500 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
03/17/2009US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists
03/17/2009US7504430 Maleiimide anti-tumor phosphatase inhibitors
03/17/2009US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
03/17/2009US7504422 Polyamine compounds
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009US7504364 Methods of making arrays and artificial receptors
03/17/2009US7504353 Asymmetric hydrogenation of methyl (Z,E)-2-(2oxotetrahydro-1H-1-pyrrolyl)-2-butenoate with [Rh-(S,S-MeDUPHOS)(COD)BF4 ] immobilised on BETA zeolite; high activity; easy recovery and reuse, which is ecologically and economically advantageous
03/17/2009CA2339283C A process for the preparation of zofenopril calcium salt
03/12/2009WO2009011551A3 Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof
03/12/2009US20090069579 Process and compound
03/12/2009US20090069575 Process For The Preparation Of (S)-Alpha-Ethyl-2-Oxo-1-Pyrrolidineacetamide And (R)- Alpha-Ethyl-2-Oxo-Pyrrolidineacetamide
03/12/2009US20090069558 Oxidatively cyclized tetrahydrobilene
03/12/2009US20090069406 Analogs of tetramic acid
03/12/2009US20090069404 Atrial fibrillation
03/12/2009US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists
03/12/2009US20090069326 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
03/12/2009US20090069252 C-glycoside derivatives and salts thereof
03/12/2009US20090068120 Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same
03/12/2009CA2684037A1 Compounds with anti-cancer activity
03/11/2009EP2032570A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032530A1 Pyrrolidine compounds as renin inhibitors
03/11/2009EP2032527A1 Process for alkenylating carboxamides
03/11/2009EP1940782B1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
03/11/2009EP1631533B1 Novel process for stereoselective reduction of beta-ketoesters
03/11/2009EP1590324B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
03/11/2009EP1566385B1 Phosphorescent compound and electroluminescent element including the same
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1165564B1 Process for preparing inhibitors of nucleoside metabolism
03/11/2009EP0976722B1 Benzamidine derivatives
03/11/2009CN101384549A Pyrrole derivative or salt thereof
03/11/2009CN101381326A 2-cyano-3-(substituted) amidine-3-phenyl acrylates compounds, preparation method and use thereof
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/11/2009CN100467440C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
03/10/2009US7501528 Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
03/10/2009US7501450 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
03/10/2009US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
03/05/2009WO2009029849A1 Prodrugs and conjugates of prenylation inhibitors
03/05/2009WO2009010454A3 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
03/05/2009WO2009005677A3 Antiviral compounds
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009US20090062553 Process and Intermediates Useful in the Preparation of Statins, Particularly Atorvastatin
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062374 Deuterium-enriched lasofoxifene
03/05/2009US20090062373 Deuterium-enriched pf-184298
03/05/2009US20090062372 Glycopyrronium Salts and Their Therapeutic Use
03/05/2009US20090062366 Pyrrolidine derivative or salt thereof
03/05/2009US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090060813 Molecular sieve ssz-82 composition of matter and synthesis thereof
03/04/2009EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
03/04/2009EP2029571A1 Substituted 3 -amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
03/04/2009EP2029541A1 Process for preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carboxylic acids
03/04/2009EP2029531A1 Alkoxyalkyl-substituted cyclic keto-enols
03/04/2009EP2029530A1 Ethenyl carboxamide derivatives useful as microbiocides
03/04/2009EP2029529A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/04/2009EP1706376B1 Imidazole derivatives, processes for preparing them and their uses
03/04/2009EP1660443B1 Cyclic amine bace-1 inhibitors having a benzamide substituent
03/04/2009EP1635816B1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
03/04/2009EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase
03/04/2009CN101379030A Sulfonamide derivatives to treat infection with hepatitis c virus
03/04/2009CN101379029A A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
03/04/2009CN101379028A Chemical compounds
03/04/2009CN101376645A Carbapenem penicillin ertapenem intermediate, and preparation and use thereof
03/04/2009CN101376644A Carbapenem penicillin ertapenem intermediate, and preparation and use thereof
03/04/2009CN101376643A Preparation of carbapenem penicillin ertapenem intermediate
03/04/2009CN101376642A Carbapenem penicillin ertapenem intermediate, and preparation and use thereof
03/04/2009CN101376641A Carbapenem penicillin ertapenem intermediate, and preparation and use thereof
03/03/2009US7498447 Treating eye diseases including glaucoma or ocular hypertension; selective prostaglandin EP2 agonists; acid-functional aryl substituted pyrrolidine compounds
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome
03/03/2009US7498358 Human ADAM-10 inhibitors
03/03/2009CA2433714C Arthritis preventing or treating agent
02/2009
02/26/2009WO2009026407A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
02/26/2009WO2009026248A2 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
02/26/2009WO2009024502A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
02/26/2009WO2008138551A3 3-(2-alkoxy-phenyl)-substituted tetramates
02/26/2009US20090054666 Liquid polymer
02/26/2009US20090054630 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 404